TW326028B - A novel physiologically active substance - Google Patents

A novel physiologically active substance

Info

Publication number
TW326028B
TW326028B TW083108799A TW83108799A TW326028B TW 326028 B TW326028 B TW 326028B TW 083108799 A TW083108799 A TW 083108799A TW 83108799 A TW83108799 A TW 83108799A TW 326028 B TW326028 B TW 326028B
Authority
TW
Taiwan
Prior art keywords
positive
negative
reaction
active substance
tissues
Prior art date
Application number
TW083108799A
Other languages
English (en)
Inventor
Uemon Konishijin
Giichi Hamada
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of TW326028B publication Critical patent/TW326028B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
TW083108799A 1993-09-28 1994-09-23 A novel physiologically active substance TW326028B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5265589A JP2594222B2 (ja) 1993-09-28 1993-09-28 新規生理活性物質−ｋｆ

Publications (1)

Publication Number Publication Date
TW326028B true TW326028B (en) 1998-02-01

Family

ID=17419225

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083108799A TW326028B (en) 1993-09-28 1994-09-23 A novel physiologically active substance

Country Status (14)

Country Link
US (1) US5560935A (zh)
EP (1) EP0645142B1 (zh)
JP (1) JP2594222B2 (zh)
KR (1) KR100189144B1 (zh)
CN (1) CN1062182C (zh)
AT (1) ATE220913T1 (zh)
AU (1) AU676081B2 (zh)
CA (1) CA2132993C (zh)
DE (1) DE69431024T2 (zh)
DK (1) DK0645142T3 (zh)
ES (1) ES2180555T3 (zh)
PT (1) PT645142E (zh)
SG (1) SG45225A1 (zh)
TW (1) TW326028B (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2588109B2 (ja) * 1993-03-19 1997-03-05 日本臓器製薬株式会社 鎮痛剤
JPH1084995A (ja) * 1996-09-12 1998-04-07 Nippon Zoki Pharmaceut Co Ltd 血液凝固第ｘｉｉ因子活性化法
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JPH1180005A (ja) * 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
JPH11139977A (ja) * 1997-11-07 1999-05-25 Nippon Zoki Pharmaceut Co Ltd Ｎｅｆ作用抑制剤
KR19990044835A (ko) * 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
AU763224B2 (en) * 1999-04-15 2003-07-17 Nippon Zoki Pharmaceutical Co., Ltd. Novel bioactivating substance
EP1110909A1 (en) * 1999-12-24 2001-06-27 Bio Minerals N.V. Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use
US6726932B2 (en) 2000-02-18 2004-04-27 Nippon Zoki Pharmaceutical Co., Ltd. Fatty acid-containing composition
EP1420641A4 (en) * 2001-08-01 2005-05-25 Anil K Chauhan IMMUNE COMPLEX
US6913900B2 (en) * 2001-08-29 2005-07-05 Nippon Zoki Pharmaceutical Co., Ltd. Plasma prekallikrein activation and kallikrein production assay
AU2003280684B2 (en) 2002-10-31 2009-06-25 Nippon Zoki Pharmaceutical Co., Ltd. Remedy for fibromyalgia
CN1207005C (zh) 2002-10-31 2005-06-22 威世药业（如皋）有限公司 含生物活性物质的兔皮和其用途
KR101307999B1 (ko) * 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
US7252834B2 (en) * 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
TWI406664B (zh) 2006-03-30 2013-09-01 Univ Kyoto 硫氧還蛋白（ｔｈｉｏｒｅｄｏｘｉｎ）產生促進劑
JP4300370B2 (ja) 2007-03-13 2009-07-22 春三 小林 上皮改善剤
EP2191836B1 (en) 2007-08-31 2012-05-23 Kyushu University, National University Corporation Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
WO2011162317A1 (ja) 2010-06-25 2011-12-29 日本臓器製薬株式会社 被検物質の判定又は評価方法
EP2627343B1 (en) 2010-10-14 2018-01-10 Nippon Zoki Pharmaceutical Co., Ltd. Agents for use for promoting the synthesis of collagen and proteoglycan in intervertebral disc cells
CN103357006B (zh) 2012-10-10 2014-10-15 日本脏器制药株式会社 含有提取物的制剂的检查方法
CA2909234C (en) 2013-04-30 2023-03-14 Nippon Zoki Pharmaceutical Co., Ltd. Extracts and preparation thereof from inflamed skins of rabbits inoculated with vaccinia virus
CN108738345A (zh) 2016-02-24 2018-11-02 国立大学法人大阪大学 试验方法
WO2018056412A1 (ja) 2016-09-23 2018-03-29 国立大学法人大阪大学 シュワン細胞分化促進剤及び末梢神経再生促進剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB697351A (en) * 1951-01-16 1953-09-23 Masuichi Takino Improved process for the manufacture of nerve sedatives
US3959566A (en) * 1974-10-21 1976-05-25 E. I. Du Pont De Nemours And Company Process for preparing polymeric surfaces to improve antistatic and soil resistant properties
US4036787A (en) * 1975-09-12 1977-07-19 Blount David H Process for the production of epoxy silicate compounds and polymers
US4039474A (en) * 1975-10-20 1977-08-02 Nalco Chemical Company Silica-alumina catalysts
US4056937A (en) * 1976-01-08 1977-11-08 Kyokado Engineering Co. Ltd. Method of consolidating soils
US4089883A (en) * 1976-07-09 1978-05-16 Blount David H Process for the production of organic hydroxy silicate compounds and their condensation products
US4104456A (en) * 1977-01-06 1978-08-01 Blount David H Process for the production of poly(allylhalide-allyl alcohol)
JPS53101515A (en) * 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS5777697A (en) * 1980-11-04 1982-05-15 Nippon Zoki Pharmaceut Co Ltd Physiologically active substance nsq
JPS57183720A (en) * 1981-05-01 1982-11-12 Junji Mitani Health drug for fish farming
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JPS59118711A (ja) * 1982-12-25 1984-07-09 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質
JPS63185398A (ja) * 1986-09-10 1988-07-30 Nippon Zoki Pharmaceut Co Ltd 生理活性物質測定法
JP2651674B2 (ja) * 1987-07-23 1997-09-10 日本臓器製薬 株式会社 新規生理活性物質及びその製造方法
US4863518A (en) * 1987-10-19 1989-09-05 Blount David H Production of polyol-alkali metal silicate glass emulsion
JP2539674B2 (ja) * 1987-11-06 1996-10-02 日本臓器製薬株式会社 新規生理活性物質
US4985254A (en) * 1987-11-06 1991-01-15 Nippon Zoki Pharmaceutical Co., Ltd. Method of treating ischemic diseases
EP0341209B1 (en) * 1988-04-30 1993-09-15 Nippon Zoki Pharmaceutical Co. Ltd. Physiologically active substances, a process for preparation and pharmaceutical compositions thereof
SE461156B (sv) * 1988-05-25 1990-01-15 Eka Nobel Ab Saett foer framstaellning av papper varvid formning och avvattning aeger rum i naervaro av en aluminiumfoerening, ett katjoniskt retentionsmedel och en polymer kiselsyra
JP2539665B2 (ja) * 1988-06-20 1996-10-02 日本臓器製薬株式会社 神経疾患治療剤
CA2052449C (en) * 1990-10-01 2000-08-01 Takao Hasegawa Flocculant for water treatment and method for producing it

Also Published As

Publication number Publication date
ES2180555T3 (es) 2003-02-16
DE69431024T2 (de) 2003-01-30
SG45225A1 (en) 1998-01-16
EP0645142B1 (en) 2002-07-24
CA2132993C (en) 1999-10-26
AU7437494A (en) 1995-04-13
DK0645142T3 (da) 2002-11-04
KR960010010A (ko) 1996-04-20
DE69431024D1 (de) 2002-08-29
US5560935A (en) 1996-10-01
CN1107365A (zh) 1995-08-30
KR100189144B1 (ko) 1999-06-01
JPH0797336A (ja) 1995-04-11
PT645142E (pt) 2002-12-31
JP2594222B2 (ja) 1997-03-26
AU676081B2 (en) 1997-02-27
CA2132993A1 (en) 1995-03-29
CN1062182C (zh) 2001-02-21
ATE220913T1 (de) 2002-08-15
EP0645142A1 (en) 1995-03-29

Similar Documents

Publication Publication Date Title
TW326028B (en) A novel physiologically active substance
Walker et al. The Covalently‐Bound Flavin of Hepatic Monoamine Oxidase: 2. Identification and Properties of Cysteinyl Riboflavin
CA2374003A1 (en) Improved cellular uptake of bioactive agents
ES2069661T3 (es) Uso de una sal muy poco soluble de un heteropoliacido para la determinacion de un analito, procedimiento correspondiente de determinacion asi como medio idoneo para ello.
ES2165212T3 (es) Composiciones estables de organosiloxanos con funciones amino y alquenilo, solubles en agua, procedimiento para su fabricacion y su uso.
DE69934179D1 (de) Zusammensetzung enthaltend, ein Antigen, ein TH-1 induzierendes Adjuvans und eine im Wasser schwer lösliche Aminosäure, zur Verwendung in der Immunisierung
BR0213380A (pt) Derivados propiÈnicos alfa-oxissubstituìdos por beta-fenila: processo para sua preparação e seu uso na preparação de compostos farmaceuticamente importantes
TR200103847T2 (tr) 3-Hidroksipropanal hazırlanması için usul
PA8476501A1 (es) Procedimiento mejorado para la preparacion de aductos de bases de schiff de aminas con o-hidro ix aldehidos y composi- ciones de materia basadas en los mismos
TR200103339T2 (tr) Geliştirilmiş çözülürlük özelliklerine sahip yeni LHRH-antagonistleri.
DK1149910T3 (da) Farmaceutisk præparat til behandling af papillomavirustumorer og -infektion
NZ336793A (en) Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
ES482415A1 (es) Procedimiento para la preparacion de la sal de 4-aminohex-5-inoico o una sal del mismo.
NO995924D0 (no) Fremgangsmåte ved fremstillingen av 1,4,7,10-tetraazacyklododekan-1,4,7-trieddiksyre og derivater derav
DE50110667D1 (de) Verfahren zur Herstellung von Organosilylalkylpolysulfanen
EP1018505A3 (en) Process for preparing a triarylamine dimer
DE60226896D1 (de) Herstellung von f(ab')2 fragmenten in saügetierzelle
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DE50110077D1 (de) Verfahren zur herstellung von liponsäure und dihydroliponsaüre
DK157888C (da) Fremgangsmaade til fremstilling af d-n-carbamoyl-alfa-aminosyrederivater og bakteriestammer til anvendelse i fremgangsmaaden
TR200200995T2 (tr) 7-amino-3-metksimetil-3-sefem-4-karbosilik asitin hazırlanmasına yönelik proses.
ID27440A (id) Proses untuk menyiapkan penengah-penengah
JPS5655200A (en) Determination of transaminase and related diagnostic kit
ATE361374T1 (de) Reporterverbindungen und verfahren zur bestimmung des lipidisierungsstatus einer zelle
TR200001671T2 (tr) L-Dihidroorotik asit elde etmek için işlem ve kullanımı.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees